Randomized controlled prospective study on treatment of mild COVID-19 with Qinghua Bihui Granules
Phase 4
Recruiting
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The mild diagnosis of COVID-19 in accordance with the Novel Coronavirus Diagnosis and Treatment Protocol for Pneumonia (Trial Version 9) published by the NHC; The patient was older than 18 years; Signed informed consent.
Exclusion Criteria
Pregnant and lactating women; Patients allergic to Chinese medicine or allergic constitution of this project; Patients with malignant tumor, liver cirrhosis, chronic renal failure (uremic stage), blood system diseases, HIV and other serious underlying diseases; Patients with long-term use of hormones, immunosuppressants and other drugs; Who suffered from severe mental illness or were unable to cooperate with the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ucleic acid conversion rate;Nucleic acid turning negative time;
- Secondary Outcome Measures
Name Time Method Tongue and pulse survey of TCM;TCM diagnosis syndrome elements;TCM syndrome scoring Scale;